Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Flu is rising rapidly, driven by a new variant. Here's what to know - 2The Specialty of Compromise: Examples from Reality
- 3Etymological Investigation Disclosed: A Survey of \Dominating New Tongues\ Language Learning Application
- 4IDF uncovers 7 km.-long Gaza terror tunnel where Hamas held Hadar Goldin
- 5Empathy and reasoning aren’t rivals – new research shows they work together to drive people to help more
- Major railway disruptions persist as Germany braces for more snow
- Defeating An inability to embrace success in Scholarly world: Individual Victories
- The Main 10 Natural life Protection Associations
- At least 30 killed in attack on Nigeria village
- Vote In favor of Your Favored Kind Of Attire
- Vote in favor of Your #1 BWM Vehicles
- Mom warns of Christmas gift hazard as daughter recovers in hospital
- From Modesty to Administration: Self-improvement in Interactive abilities
- The Force of Mentorship: Self-improvement through Direction
